Selectivity among monoamine oxidase inhibitors and its possible importance for development of antidepressant drugs
- 31 December 1978
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology
- Vol. 2 (3), 303-311
- https://doi.org/10.1016/0364-7722(78)90088-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated ratsLife Sciences, 1978
- Combined Tricyclic—MAOI Therapy for Refractory Depression: A Review, with Guidelines for Appropriate UsageThe Journal of Clinical Pharmacology, 1978
- Inhibition of monoamine oxidase by N-phenacyl-cyclopropylamineBiochemical Pharmacology, 1978
- Monoamine oxidase A and B: A useful concept?Biochemical Pharmacology, 1978
- PRESSOR AMINES AND MONOAMINE-OXIDASE INHIBITORS FOR TREATMENT OF POSTURAL HYPOTENSION IN AUTONOMIC FAILUREThe Lancet, 1978
- Further studies on the effects of N-cyclopropyl-p-chloroamphetamine in rat brainNeuropharmacology, 1977
- A review of combined tricyclic and MAOI therapyComprehensive Psychiatry, 1977
- IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASEThe Lancet, 1977
- Inhibition of monoamine oxidase by 3-amino-2-oxazolidinone and 2-hydroxy-ethylhydrazineCellular and Molecular Life Sciences, 1971
- MONOAMINE-OXIDASE INHIBITORS, BROAD BEANS, AND HYPERTENSIONThe Lancet, 1964